WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596849

CAS#: 23846-71-1

Description: L-Alprenolol is a non-selective beta blocker as well as a 5-HT1A and 5-HT1B receptor antagonist, used in the treatment of angina pectoris.

Chemical Structure

CAS# 23846-71-1

Theoretical Analysis

MedKoo Cat#: 596849
Name: L-Alprenolol
CAS#: 23846-71-1
Chemical Formula: C15H23NO2
Exact Mass: 249.1729
Molecular Weight: 249.35
Elemental Analysis: C, 72.25; H, 9.30; N, 5.62; O, 12.83

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: L-Alprenolol; (-)-Alprenolol; (S)-Alprenolol;

IUPAC/Chemical Name: 1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol


InChi Code: InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3


Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 249.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Rao NV, Macchi C, Tortorella C, Ahmad MF, Nussdorfer GG. Neuropeptide Y and glucocorticoid secretion from guinea pig adrenal gland: an in vivo and in vitro study. Int J Mol Med. 2007 Sep;20(3):345-9. PubMed PMID: 17671739.

2: Andreis PG, Tortorella C, Ziolkowska A, Spinazzi R, Malendowicz LK, Neri G, Nussdorfer GG. Evidence for a paracrine role of endogenous adrenomedullary galanin in the regulation of glucocorticoid secretion in the rat adrenal gland. Int J Mol Med. 2007 Mar;19(3):511-5. PubMed PMID: 17273801.

3: Hochol A, Tortorella C, Ricinski M, Ziolkowska A, Nussdorfer GG, Malendowicz LK. Effects of neuropeptides B and W on the rat pituitary-adrenocortical axis: in vivo and in vitro studies. Int J Mol Med. 2007 Feb;19(2):207-11. PubMed PMID: 17203193.

4: Raha D, Tortorella C, Neri G, Prasad A, Raza B, Raskar R, Dubey R, Sen NS, Macchi C, Malendowicz LK, Ahmad MF, Nussdorfer GG. Atrial natriuretic peptide enhances cortisol secretion from guinea-pig adrenal gland: evidence for an indirect paracrine mechanism probably involving the local release of medullary catecholamines. Int J Mol Med. 2006 Apr;17(4):633-6. PubMed PMID: 16525720.

5: Albertin G, Malendowicz LK, Tortorella C, Mazzocchi G, Nussdorfer GG. Evidence for a paracrine role of adrenomedullin in the physiological resetting of aldosterone secretion by rat adrenal zona glomerulosa. Peptides. 2000 Mar;21(3):413-7. PubMed PMID: 10793225.

6: Albertin G, Malendowicz LK, Macchi C, Markowska A, Nussdorfer GG. Cerebellin stimulates the secretory activity of the rat adrenal gland: in vitro and in vivo studies. Neuropeptides. 2000 Feb;34(1):7-11. PubMed PMID: 10688962.

7: Rebuffat P, Macchi C, Malendowicz LK, Nussdorfer GG. Comparison of the signaling mechanisms involved in the ETB receptor-mediated secretagogue action of endothelin-1 on dispersed zona glomerulosa cells and capsule-zona glomerulosa preparations of the rat adrenal gland. Int J Mol Med. 2000 Jan;5(1):43-7. PubMed PMID: 10601572.

8: Rebuffat P, Mazzocchi G, Macchi C, Malendowicz LK, Gottardo G, Nussdorfer GG. Mechanisms and receptor subtypes involved in the stimulatory action of endothelin-1 on rat adrenal zona glomerulosa. Int J Mol Med. 1999 Mar;3(3):307-10. PubMed PMID: 10028057.

9: Mazzocchi G, Andreis PG, De Caro R, Aragona F, Gottardo L, Nussdorfer GG. Cerebellin enhances in vitro secretory activity of human adrenal gland. J Clin Endocrinol Metab. 1999 Feb;84(2):632-5. PubMed PMID: 10022429.

10: Misane I, Johansson C, Ogren SO. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br J Pharmacol. 1998 Oct;125(3):499-509. PubMed PMID: 9806333; PubMed Central PMCID: PMC1565647.

11: Mazzocchi G, Gottardo G, Macchi V, Malendowicz LK, Nussdorfer GG. The AT2 receptor-mediated stimulation of adrenal catecholamine release may potentiate the AT1 receptor-mediated aldosterone secretagogue action of angiotensin-II in rats. Endocr Res. 1998 Feb;24(1):17-28. PubMed PMID: 9553752.

12: Andreis PG, Neri G, Prayer-Galetti T, Rossi GP, Gottardo G, Malendowicz LK, Nussdorfer GG. Effects of adrenomedullin on the human adrenal glands: an in vitro study. J Clin Endocrinol Metab. 1997 Apr;82(4):1167-70. PubMed PMID: 9100590.

13: Nussdorfer GG, Rossi GP, Mazzocchi G. Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides. 1997;18(7):1079-89. Review. PubMed PMID: 9357070.

14: Mazzocchi G, Musajo F, Neri G, Gottardo G, Nussdorfer GG. Adrenomedullin stimulates steroid secretion by the isolated perfused rat adrenal gland in situ: comparison with calcitonin gene-related peptide effects. Peptides. 1996;17(5):853-7. PubMed PMID: 8844777.

15: Neri G, Andreis PG, Prayer-Galetti T, Rossi GP, Malendowicz LK, Nussdorfer GG. Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab. 1996 Jan;81(1):169-73. PubMed PMID: 8550747.

16: Andreis PG, Malendowicz LK, Belloni AS, Nussdorfer GG. Effects of pituitary adenylate-cyclase activating peptide (PACAP) on the rat adrenal secretory activity: preliminary in-vitro studies. Life Sci. 1995;56(2):135-42. PubMed PMID: 7823760.

17: Mazzocchi G, Malendowicz LK, Belloni AS, Nussdorfer GG. Adrenal medulla is involved in the aldosterone secretagogue effect of substance P. Peptides. 1995;16(2):351-5. PubMed PMID: 7540295.

18: Bjorvatn B, Neckelmann D, Ursin R. The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats. Pharmacol Biochem Behav. 1992 May;42(1):49-56. PubMed PMID: 1388278.

19: Ghahary A, Cheng KW. Identification and characterization of the beta-adrenergic receptor on neuroblastoma x glioma hybrid NG108-15 cells. Cell Mol Neurobiol. 1990 Sep;10(3):337-50. PubMed PMID: 2174741.

20: Segal J, Ingbar SH. Evidence that an increase in cytoplasmic calcium is the initiating event in certain plasma membrane-mediated responses to 3,5,3'-triiodothyronine in rat thymocytes. Endocrinology. 1989 Apr;124(4):1949-55. PubMed PMID: 2538316.